Impurity testing of biotherapeutics? Try the new Gyrolab CHO-HCP E3G Kit. Now available in a ready to use kit optimized for Gyrolab® Systems.
Other than specificity, the affinity (KD) of an antibody reagent binding to a drug target is the most important property that drives PK, ADA and NAb assay performance.
Gyros Webinar: Rapid in-solution equilibrium approach to KD determination of biotherapeutic drug candidates
Current technologies for the development of new antibody biotherapeutic drug substances enable the development of very high affinity candidates.